Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study

被引:3
|
作者
Gulpen, Anouk J. W. [1 ,2 ,3 ]
Braeken, Dionne C. W. [1 ]
Schalla, Simon [2 ,4 ]
Ten Cate, Hugo [1 ,2 ,3 ]
Crijns, Harry J. [2 ,4 ]
Ten Cate-Hoek, Arina J. [1 ,2 ]
机构
[1] Maastricht & Lab Clin Thrombosis & Hemostasis, Thrombosis Expert Ctr, Maastricht, Netherlands
[2] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands
[3] Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands
[4] Maastricht Univ, Med Ctr, Dept Cardiol & Radiol, Maastricht, Netherlands
关键词
Direct oral anticoagulants; Thrombosis; Adherence; WARFARIN; DABIGATRAN; PERSISTENCE; APIXABAN; THERAPY; SCALE;
D O I
10.1159/000524094
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Long-term treatment with direct oral anticoagulants (DOAC) is required for the majority of patients with nonvalvular atrial fibrillation (AF) to prevent ischemic stroke and systemic embolism. Adherence to therapy may impact clinical outcomes. Therefore, the purpose of this study was to assess the potential impact of structured follow-up on long-term adherence to DOAC therapy compared to standard care. Methods: This is a cross sectional study on the implementation phase of medication adherence to DOACs, comparing patients with AF following completion of structured follow-up of minimally 1 year with those who received standard care. All patients used DOACs for more than 2 years and completed a questionnaire on adherence. Adherence was measured with the Morisky Medication Adherence Scale-8 (MMAS-8) score and assessed via an online web portal. Results: A total of 212 patients were included. The mean MMAS-8 score was 7.55 (SD 0.93) after structured follow-up and 7.25 (SD 1.01) for standard care; p = 0.045. Following structured follow-up 64.1% of patients had a high adherence (MMAS score of 8) compared to 50% receiving standard care; p = 0.05. Patients following structured follow-up on a once daily DOAC regime had higher MMAS-8 scores compared to those on a twice daily regime; 7.74 (SD 0.74) versus 7.00 (SD 1.22); p < 0.001. The rates of minor bleedings were 10.6% versus 21.4% respectively, p = 0.038. Conclusion: In patients on long-term DOAC treatment, adherence to therapy was significantly increased after receiving an initial period of structured follow-up compared to standard care. Additionally, adherence to DOAC therapy was higher with once-daily treatment regimen. Significant more minor bleedings were reported in the standard care group. These results indicate that implementation of structured follow-up of patients with AF using DOACs merits further evaluation. (c) 2022 The Author(s). Published by S. Karger AG, Basel
引用
收藏
页码:476 / 483
页数:8
相关论文
共 50 条
  • [1] Association between medication adherence and illness perceptions in atrial fibrillation patients treated with direct oral anticoagulants: An observational cross-sectional pilot study
    Miyazaki, Motoyasu
    Nakashima, Akio
    Nakamura, Yoshihiko
    Sakamoto, Yuya
    Matsuo, Koichi
    Goto, Miwa
    Uchiyama, Masanobu
    Okamura, Keisuke
    Mitsutake, Ryoko
    Urata, Hidenori
    Kamimura, Hidetoshi
    Imakyure, Osamu
    PLOS ONE, 2018, 13 (09):
  • [2] Long-Term Medication Adherence Trajectories to Direct Oral Anticoagulants and Clinical Outcomes in Patients With Atrial Fibrillation
    An, Jaejin
    Bider, Zoe
    Luong, Tiffany Q.
    Cheetham, T. Craig
    Lang, Daniel T.
    Fischer, Heidi
    Reynolds, Kristi
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (21):
  • [3] Adherence to direct or vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a long-term observational study
    Shahrzad Salmasi
    Abdollah Safari
    Mary A. De Vera
    Tanja Högg
    Larry D. Lynd
    Mieke Koehoorn
    Arden R. Barry
    Jason G. Andrade
    Marc W. Deyell
    Kathy L. Rush
    Yinshan Zhao
    Peter Loewen
    Journal of Thrombosis and Thrombolysis, 2024, 57 : 437 - 444
  • [4] Adherence to direct or vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a long-term observational study
    Salmasi, Shahrzad
    Safari, Abdollah
    De Vera, Mary A.
    Hoegg, Tanja
    Lynd, Larry D.
    Koehoorn, Mieke
    Barry, Arden R.
    Andrade, Jason G.
    Deyell, Marc W.
    Rush, Kathy L.
    Zhao, Yinshan
    Loewen, Peter
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (03) : 437 - 444
  • [5] Use of Direct Acting Oral Anticoagulants in Elderly Patients with Atrial Fibrillation: A Multicenter, Cross-Sectional Study in Spain
    Diez-Villanueva, Pablo
    Cosin-Sales, Juan
    Roldan-Schilling, Vanesa
    Barrios, Vivencio
    Riba-Artes, Diana
    Gavin-Sebastian, Olga
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (03)
  • [6] Direct Medical Cost of Stroke and the Cost-Effectiveness of Direct Oral Anticoagulants in Atrial Fibrillation-Related Stroke: A Cross-Sectional Study
    Azahar, Siti Norain
    Sulong, Saperi
    Wan Zaidi, Wan Asyraf
    Muhammad, Norliza
    Kamisah, Yusof
    Masbah, Norliana
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (03)
  • [7] Long-Term Clinical Outcomes of Underdosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Atrial Flutter
    Ashraf, Hasan
    Agasthi, Pradyumna
    Shanbhag, Anusha
    Mehta, Ramila A.
    Rattanawong, Pattara
    Allam, Mohamed
    Pujari, Sai Harika
    Mookadam, Farouk
    Freeman, William K.
    Srivathsan, Komandoor
    Sorajja, Dan
    Shen, Win-Kuang
    Noseworthy, Peter A.
    Yang, Eric H.
    El Masry, Hicham Z.
    Yao, Xiaoxi
    Mulpuru, Siva K.
    Beohar, Nirat
    Holmes, David R., Jr.
    Arsanjani, Reza
    AMERICAN JOURNAL OF MEDICINE, 2021, 134 (06): : 788 - 796
  • [8] Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk
    Komen, Joris J.
    Heerdink, Eibert R.
    Klungel, Olaf H.
    Mantel-Teeuwisse, Aukje K.
    Forslund, Tomas
    Wettermark, Bjorn
    Hjemdahl, Paul
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (F11) : F72 - F80
  • [9] Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study
    Banerjee, Amitava
    Benedetto, Valerio
    Gichuru, Philip
    Burnell, Jane
    Antoniou, Sotiris
    Schilling, Richard J.
    Strain, William David
    Ryan, Ronan
    Watkins, Caroline
    Marshall, Tom
    Sutton, Chris J.
    HEART, 2020, 106 (02) : 119 - +
  • [10] Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants
    Garkina, Svetlana V.
    Vavilova, Tatiana V.
    Lebedev, Dmitry S.
    Mikhaylov, Evgeny N.
    JOURNAL OF GERIATRIC CARDIOLOGY, 2016, 13 (09) : 807 - 810